Oral Vancomycin for Secondary Prophylaxis of Clostridium Difficile Infection (CDI)
Status:
Recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to gain further knowledge regarding the effectiveness of
vancomycin prophylaxis in preventing Clostridium difficile infections in order to guide
physicians' practices.